Cargando…
Disulfiram can inhibit MERS and SARS coronavirus papain-like proteases via different modes
Severe acute respiratory syndrome coronavirus (SARS-CoV) emerged in southern China in late 2002 and caused a global outbreak with a fatality rate around 10% in 2003. Ten years later, a second highly pathogenic human CoV, MERS-CoV, emerged in the Middle East and has spread to other countries in Europ...
Autores principales: | Lin, Min-Han, Moses, David C., Hsieh, Chih-Hua, Cheng, Shu-Chun, Chen, Yau-Hung, Sun, Chiao-Yin, Chou, Chi-Yuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7113793/ https://www.ncbi.nlm.nih.gov/pubmed/29289665 http://dx.doi.org/10.1016/j.antiviral.2017.12.015 |
Ejemplares similares
-
Structural and functional characterization of MERS coronavirus papain-like protease
por: Lin, Min-Han, et al.
Publicado: (2014) -
Porcine epidemic diarrhea virus papain-like protease 2 can be noncompetitively inhibited by 6-thioguanine
por: Chu, Hsu-Feng, et al.
Publicado: (2018) -
Differential domain structure stability of the severe acute respiratory syndrome coronavirus papain-like protease
por: Chou, Ya-Wen, et al.
Publicado: (2012) -
Thiopurine analogues inhibit papain-like protease of severe acute respiratory syndrome coronavirus
por: Chou, Chi-Yuan, et al.
Publicado: (2008) -
Decoupling deISGylating and deubiquitinating activities of the MERS virus papain-like protease
por: Clasman, Jozlyn R., et al.
Publicado: (2020)